1 results match your criteria: "WHO Collaborating Center for Emerging Infections and Biological Threats[Affiliation]"
Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey.
J Antimicrob Chemother
October 2021
Robert Koch Institute, WHO Collaborating Center for Emerging Infections and Biological Threats, Berlin, Germany.
Objectives: The COVID-19 pandemic has had a substantial impact on health systems. The WHO Antimicrobial Resistance (AMR) Surveillance and Quality Assessment Collaborating Centres Network conducted a survey to assess the effects of COVID-19 on AMR surveillance, prevention and control.
Methods: From October to December 2020, WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) national focal points completed a questionnaire, including Likert scales and open-ended questions.